• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Cathepsin D and breast cancer.

作者信息

Westley B R, May F E

机构信息

Department of Pathology, Royal Victoria Infirmary, Newcastle upon Tyne, U.K.

出版信息

Eur J Cancer. 1996 Jan;32A(1):15-24. doi: 10.1016/0959-8049(95)00530-7.

DOI:10.1016/0959-8049(95)00530-7
PMID:8695224
Abstract
摘要

相似文献

1
Cathepsin D and breast cancer.组织蛋白酶D与乳腺癌
Eur J Cancer. 1996 Jan;32A(1):15-24. doi: 10.1016/0959-8049(95)00530-7.
2
Cathepsin D in breast cancer.乳腺癌中的组织蛋白酶D
Breast Cancer Res Treat. 1990 Jul;16(1):3-13. doi: 10.1007/BF01806570.
3
A hormone-regulated pro-cathepsin D secreted by human mammary cancer cells.一种由人乳腺癌细胞分泌的激素调节型组织蛋白酶D前体。
Biochem Soc Trans. 1989 Feb;17(1):31-3. doi: 10.1042/bst0170031.
4
Relation between cathepsin D expression and other prognostic factors in breast carcinomas.乳腺癌中组织蛋白酶D表达与其他预后因素的关系。
Clin Chem. 1995 Nov;41(11):1585-91.
5
Immunoradiometric assay of pro-cathepsin D in breast cancer cytosol: relative prognostic value versus total cathepsin D.乳腺癌细胞溶质中组织蛋白酶D前体的免疫放射分析：与总组织蛋白酶D相比的相对预后价值
Eur J Cancer. 1993;29A(9):1248-51. doi: 10.1016/0959-8049(93)90066-o.
6
Evaluation of cathepsin D as a prognostic factor in breast cancer.组织蛋白酶D作为乳腺癌预后因素的评估
Breast Cancer Res Treat. 1993;24(3):219-26. doi: 10.1007/BF01833262.
7
Prognostic value of cathepsin D in breast cancer: comparison of immunohistochemical and immunoradiometric detection methods.组织蛋白酶D在乳腺癌中的预后价值：免疫组织化学和免疫放射测定检测方法的比较
J Clin Pathol. 1996 Jan;49(1):57-64. doi: 10.1136/jcp.49.1.57.
8
[Estrogens, cathepsin D and metastasis in cancers of the breast and ovary: invasion or proliferation?].[雌激素、组织蛋白酶D与乳腺癌和卵巢癌转移：侵袭还是增殖？]
C R Seances Soc Biol Fil. 1998;192(2):241-51.
9
Cathepsin D in breast cancer: a tissue marker associated with metastasis.
Eur J Cancer. 1992;28A(11):1780-3. doi: 10.1016/0959-8049(92)90003-k.
10
Cathepsin D and prognosis in breast cancer: one piece of a larger puzzle?
Hum Pathol. 1996 Sep;27(9):869-71. doi: 10.1016/s0046-8177(96)90211-7.

引用本文的文献

1
Graphene Oxide-Based Targeting of Extracellular Cathepsin D and Cathepsin L As A Novel Anti-Metastatic Enzyme Cancer Therapy.基于氧化石墨烯靶向细胞外组织蛋白酶D和组织蛋白酶L作为一种新型抗转移酶癌症疗法
Cancers (Basel). 2019 Mar 6;11(3):319. doi: 10.3390/cancers11030319.
2
The Potential Role of the Proteases Cathepsin D and Cathepsin L in the Progression and Metastasis of Epithelial Ovarian Cancer.蛋白酶组织蛋白酶D和组织蛋白酶L在上皮性卵巢癌进展和转移中的潜在作用
Biomolecules. 2015 Nov 20;5(4):3260-79. doi: 10.3390/biom5043260.
3
Overexpression of both catalytically active and -inactive cathepsin D by cancer cells enhances apoptosis-dependent chemo-sensitivity.
癌细胞对具有催化活性和无催化活性的组织蛋白酶D的过表达均增强了依赖凋亡的化学敏感性。
Oncogene. 2006 Mar 23;25(13):1967-73. doi: 10.1038/sj.onc.1209221.
4
Cathepsin D-related disease-free interval in pT1 primary breast carcinomas: a pilot study.pT1期原发性乳腺癌中组织蛋白酶D相关的无病生存期：一项初步研究。
Clin Exp Metastasis. 2005;22(4):363-8. doi: 10.1007/s10585-005-1265-8.
5
Cathepsin D specifically cleaves the chemokines macrophage inflammatory protein-1 alpha, macrophage inflammatory protein-1 beta, and SLC that are expressed in human breast cancer.组织蛋白酶D特异性切割在人类乳腺癌中表达的趋化因子巨噬细胞炎性蛋白-1α、巨噬细胞炎性蛋白-1β和SLC。
Am J Pathol. 2003 Apr;162(4):1183-90. doi: 10.1016/s0002-9440(10)63914-4.
6
Prognostic factors in breast cancer: current and new predictors of metastasis.乳腺癌的预后因素：转移的当前及新预测指标
J Mammary Gland Biol Neoplasia. 2001 Oct;6(4):375-92. doi: 10.1023/a:1014778713034.
7
High expression of the trefoil protein TFF1 in interval breast cancers.三叶因子蛋白TFF1在间期乳腺癌中的高表达。
Am J Pathol. 2001 Jul;159(1):215-21. doi: 10.1016/S0002-9440(10)61687-2.
8
The Expression of Lysosomal Proteinases and Their Inhibitors in Breast Cancer: Possible Relationship to Prognosis of the Disease.
Pathol Oncol Res. 1997;3(2):89-99. doi: 10.1007/BF02907801.
9
Cathepsin-D, urokinase plasminogen activator and type-1 plasminogen activator inhibitor in early breast cancer: an immunohistochemical study of prognostic value and relations to tenascin-C and other factors.组织蛋白酶-D、尿激酶型纤溶酶原激活剂及1型纤溶酶原激活剂抑制剂在早期乳腺癌中的表达：一项关于预后价值及与腱生蛋白-C和其他因素关系的免疫组织化学研究
Br J Cancer. 1999 Apr;80(1-2):167-74. doi: 10.1038/sj.bjc.6690336.
10
Cathepsin-D in primary breast cancer: prognostic evaluation involving 2810 patients.原发性乳腺癌中的组织蛋白酶-D：对2810例患者的预后评估
Br J Cancer. 1999 Jan;79(2):300-7. doi: 10.1038/sj.bjc.6690048.